AETERNA ZENTARIS PRESENTED POSITIVE IN VIVO DATA ON ZEN-019, AN ORAL, LHRH ANTAGONIST PEPTIDOMIMETIC

AEterna Zentaris Inc. today announced that it presented Abstract No. P3-257 during a poster presentation entitled "ZEN-019, A Peptidomimetic from a New Class of Orally Active GnRH (LHRH) Antagonists," on Monday, June 26, 2006 in the Exhibit Hall of the Boston Convention & Exhibition Center in Boston, Massachusetts, during the 2006 Annual Meeting of the Endocrine Society.

Drug Newswire (http://www.drugnewswire.com/2696/)